The heat shock protein-CD91 pathway mediates tumor immunosurveillance
Authors:
Open Access
- 9 April 2014
- journal article
- Published by Taylor & Francis in OncoImmunology
- Vol. 3 (4) , e28222
Abstract
Tumor immunosurveillance can be readily observed in mice and humans. Here, we examine how T-cell responses are primed during tumorigenesis, a condition in which immunostimulatory antigens are extraordinarily scarce. We recently demonstrated that the HSP-CD91 pathway is indispensable for antigen cross-presentation, and thus immunosurveillance, in cancer.Keywords
This publication has 10 references indexed in Scilit:
- Establishment of Tumor-Associated Immunity Requires Interaction of Heat Shock Proteins with CD91Cancer Immunology Research, 2014
- Identification of the Cellular Sentinels for Native Immunogenic Heat Shock Proteins In VivoThe Journal of Immunology, 2013
- CD91-dependent programming of T-helper cell responses following heat shock protein immunizationNature Communications, 2011
- Ovalbumin-Derived Precursor Peptides Are Transferred Sequentially from gp96 and Calreticulin to MHC Class I in the Endoplasmic ReticulumThe Journal of Immunology, 2010
- Heat-shock protein-based vaccines for cancer and infectious diseaseExpert Review of Vaccines, 2008
- Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cellsNature Immunology, 2005
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In VivoThe Journal of Immunology, 2001
- Somatic activation of the K-ras oncogene causes early onset lung cancer in miceNature, 2001
- Cancer risk after renal transplantation in the nordic countries, 1964–1986International Journal of Cancer, 1995